Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Ca...
Q2 2026
Aug 4, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Nov 4, 2025